On July 9 Susquehanna raised its price target on Boeing to $252 from $240 and affirmed a positive rating on the shares, ...

San Jose, California-based PayPal Holdings, Inc. (PYPL) operates a technology platform that enables digital payments for ...

GXO’s first quarter results were supported by notable revenue growth and exceeded Wall Street expectations, prompting a ...

In an effort to equip older U.S. aircraft with new engines and to sidestep U.S. tariffs on imports from Europe, Delta Air ...

Investing.com - JPMorgan has maintained its Overweight rating and $800.00 price target on Regeneron Pharmaceuticals (NASDAQ: REGN) ahead of the company’s second-quarter earnings report.

The company is scheduled to release its first-quarter earnings report on April 24, 2025, providing further insights into its financial performance.

Get the latest news and real-time alerts from L3Harris Technologies, Inc. (LHX) stock at Seeking Alpha.